Expanded tuberculosis screening does not speed up treatment initiation or improve survival in hospitalized patients with HIV
_in_a_Auramine-Rhodamine_fluorescent_stained_smear_of_Mycobacterium_tuberculosis_complex_(MTBC)_of_modified_Middlebrook_7H9_Broth.jpg){kind=link}
According to the EXULTANT trial, adding molecular tests on sputum, urine and stool samples does not appear to outperform the standard WHO-recommended diagnostic approach.
Registered users, subscribers or members - SIGN IN
To continue reading this article
Membership
Included as a benefit
Members of Applied Microbiology International have unlimited access to The Microbiologist as a benefit of membership. Just sign in with your usual membership credentials.
Find out more about how to join.
Register
FREE
Want to read more before deciding on a subscription? It only takes a minute to sign up for a free account and you’ll get to enjoy more free content each month.
Subscribe
3.75 per month / £35 annually
Get unlimited access to The Microbiologist.